CF PHARMTECH (02652.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov12

Changfeng Pharmaceutical Adopts 2025 H-Share Incentive Trust Plan

23:39

Oct21

Changfeng Pharmaceutical Obtains Overseas Approval and Reaches Procurement Cooperation

07:18

Oct16

Changfeng Pharma Successfully Listed, Notable Achievements in Respiratory Therapeutics

13:12

Sep25

CF PHARMTECH released FY2024 Annual Earnings on September 25, 2025 (BJT) with actual revenue of HKD 657.88 M and actual EPS of HKD 0.0615

15:00

CF PHARMTECH released FY2024 Q1 earnings on September 25, 2025 (BJT), actual revenue HKD 151.47 M, actual EPS HKD 0.0179

15:00

CF PHARMTECH released FY2025 Q1 earnings on September 25 (BJT), actual revenue HKD 145.59 M, actual EPS HKD 0.037

15:00

Schedules & Filings

Schedules

Filings

Oct8

IPO(CST)

Listing Price HKD 14.75

Sep25

Earning Release(CST)

FY2025 Q1 Earning Release (HKD) Revenue 145.59 M, Net Income 13.72 M, EPS 0.037

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More